Hanny Yeshua

Response Letter to: Expanding Perspectives on FIB-4 as a Predictor of Hepatic and Extrahepatic Malignancy Risk.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: June 08, 2025

Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 14, 2025

The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 09, 2024

Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: January 13, 2021

Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 30, 2020

Comparison of antidepressant use between adult populations living in urban and rural communities in Israel.

Journal: Family practice

Published: September 06, 2018

Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.

Journal: European journal of preventive cardiology

Published: March 09, 2018

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.

Journal: World journal of gastroenterology

Published: December 03, 2016

Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 25, 2016

Response Letter to: Expanding Perspectives on FIB-4 as a Predictor of Hepatic and Extrahepatic Malignancy Risk.

Response Letter to: Expanding Perspectives on FIB-4 as a Predictor of Hepatic and Extrahepatic Malignancy Risk.

Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort Study.

Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort Study.

The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study.

The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study.

Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"

Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"

Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population.

Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population.

Comparison of antidepressant use between adult populations living in urban and rural communities in Israel.

Comparison of antidepressant use between adult populations living in urban and rural communities in Israel.

Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.

Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.

Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.

Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.

The management of pre-hypertension in primary care: Is it adequate?

The management of pre-hypertension in primary care: Is it adequate?

Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.

Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.

Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.

Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.